未登录

P

Punniyakoti T. Veeraveedu

Chettinad Academy of Research and Education

H指数:36

被引数:3,888

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Emerging insights into MicroRNA therapeutics and diagnostics for atherosclerotic cardiovascular disease: A narrative review

International Journal of Biological Macromolecules

IF8.5

2026-01-260

PRE

A molecular perspective on cardioprotective potential of Moringa oleifera Lam. and its Nano-formulations

IF8.3

2026-01-210

PRE

Synthesis, characterization, DFT analysis, molecular docking, molecular dynamics, ADMET and anti-breast cancer activity of novel indole–oxadiazole derivatives

新型吲哚-恶二唑衍生物的合成、表征、DFT分析、分子对接、分子动力学、ADMET及抗乳腺癌活性

Journal of Molecular Structure

IF4.7

2025-11-020

PRE

Nanotechnology-empowered strategies in treatment of skin cancer

ENVIRONMENTAL RESEARCH

IF7.7

2023-10-0129

PRE

Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases

CYTOKINE & GROWTH FACTOR REVIEWS

IF11.8

2023-06-017

PRE

Nanocrystals as an emerging nanocarrier for the management of dermatological diseases

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2023-05-0117

PRE

Immunoliposomes as an emerging nanocarrier for breast cancer therapy

EUROPEAN POLYMER JOURNAL

IF6.3

2023-02-0127

PRE

An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes

JOURNAL OF ADVANCED RESEARCH

IF13

2020-05-0162

OAAI

The signaling interplay of GSK-3β in myocardial disorders

DRUG DISCOVERY TODAY

IF7.5

2020-04-0127

PREAI

Novel cyanoacetamide integrated phenothiazines: Synthesis, characterization, computational studies and in vitro antioxidant and anticancer evaluations

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2020-01-0140

PREAI

An insight into the medicinal perspective of synthetic analogs of indole: A review

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-10-01266

PREAI

Construction of a novel quinoxaline as a new class of Nrf2 activator

IF4.6

2019-09-2413

OAAI

Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future

DRUG DISCOVERY TODAY

IF7.5

2018-03-0119

PREAI

Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2017-10-0195

PREAI

Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress

BIOCHEMICAL PHARMACOLOGY

IF5.6

2017-08-0157

PREAI

A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2016-12-0141

PREAI

Albiglutide: Is a better hope against diabetes mellitus?

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2016-02-0113

PREAI

Molecular understanding of curcumin in diabetic nephropathy

DRUG DISCOVERY TODAY

IF7.5

2013-08-0150

PREAI

Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor

FREE RADICAL RESEARCH

IF2.9

2012-05-1428

PREAI

Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2012-04-0166

PREAI